Tier 2 access fee (36 month extension)
Ended Purchase Order Awarded Last action
- Contract number
- 75N92025K00001
- Awardee
-
UK Biobank LIMITED UEI Q834HNV69B21
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,330
Award facts
- Contract value 100% obligated
- $10,330.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Great Britain, United Kingdom
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$103 | |
| Original award | $10,434 |
About this award
The National Heart Lung and Blood Institute (NHLBI), a civilian component of the National Institutes of Health, awarded a $10,330.40 firm fixed-price purchase order to UK Biobank LIMITED for Tier 2 data access fees under a 36-month extension. The contract, which carries no set-aside designation, is scheduled for ultimate completion on December 17, 2025, with an award date of July 9, 2025. UK Biobank LIMITED, a non-profit organization registered in SAM.gov and based in Stockport, United Kingdom, will perform services at its location in Great Britain, delivering de-identified medical and genetic datasets to support NHLBI-funded research initiatives.
UK Biobank LIMITED serves as a critical intermediary for biomedical research by providing researchers access to comprehensive datasets containing genetic, lifestyle, and health information from over 500,000 UK participants. Under this Tier 2 access arrangement, NHLBI researchers will gain access to whole exome and genome data linked to electronic health records, facilitating studies on heart, lung, and blood disorders as well as related pathogenic variants and age-associated conditions. This contract represents a continuation of ongoing collaborative arrangements between NHLBI and UK Biobank LIMITED, enabling federally funded researchers to leverage large-scale, de-identified population health data for advanced biomedical investigations across multiple scientific disciplines.
Quick answers
Who was awarded contract 75N92025K00001?
75N92025K00001 was awarded to UK Biobank LIMITED by National Heart Lung and Blood Institute (National Institutes of Health) on July 9, 2025.
How much is contract 75N92025K00001 worth?
The government has obligated $10,330 on 75N92025K00001.
Was contract 75N92025K00001 competed?
The extent of competition for 75N92025K00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award